![Nvidia leapfrogs Apple, Microsoft to take crown as most valuable company](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEK330I8_L.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1011 | 1122 | 1084 | 1250 | 1405 |
Fund Return | 4.22% | 1.11% | 12.18% | 2.74% | 4.57% | 3.46% |
Place in category | 29 | 64 | 8 | 37 | 26 | 11 |
% in Category | 12 | 27 | 4 | 22 | 18 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Alumot Kabin 20 80 | 438.79M | 3.67 | 2.06 | - | ||
Forte Equity | 197.52M | 8.45 | 1.58 | - | ||
Axioma Bonds + 30 | 83.13M | 4.30 | 3.00 | 2.62 | ||
Kabin Global Equity | 69.49M | 10.87 | 3.59 | - | ||
Kabin Investments Leveraged | 29.88M | 12.44 | 2.81 | 14.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IL0051257942 | 1.53B | 3.12 | 3.29 | - | ||
Yelin Lapidot 30 70 | 1.47B | 2.96 | 2.23 | - | ||
Meitav 20 80 | 1.16B | 2.12 | 1.63 | - | ||
Yelin Lapidot 20/80 | 1.14B | 1.99 | 1.64 | 2.94 | ||
IL0051236664 | 1.06B | 3.22 | 3.27 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR® S&P 500 ETF Trust | - | 4.37 | - | - | |
Invesco NASDAQ 100 ETF | - | 3.46 | - | - | |
KSM 4A S&P 500 Currency Hedged | IL0011466047 | 1.84 | 5,307 | +1.22% | |
Israel 2.8 29-Nov-2052 | IL0011840761 | 1.80 | 64.800 | +1.25% | |
Zur Shamir Holdings Ltd 3.7 30-Jun-2028 | IL0073001716 | 1.71 | 112.900 | +0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Neutral | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review